Whole blood miRNA expression signatures as predictors of neoadjuvant chemotherapy response in triple-negative breast cancer
{{output}}
Background: Triple negative breast cancer (TNBC) is an aggressive malignancy distinguished by resistance to standard breast cancer therapies. The absence of reliable prognostic tools hinders the ability to predict therapeutic res... ...
